CCND1 and breast cancer: In addition, targeting SOX2 in breast cancer cell lines have shown that siRNA-mediated knock-down of SOX2 resulted in cell cycle arrest by down-regulation of Cyclin D1 and this arrest in cell cycle was accompanied by an inhibition of tumor cell proliferation in xenograft models [18].